Nano Code – Finding the Right Drug for Treating Cancer Using Nano-Particles in a Patient
Grant Amount: NIS 4.2 Million
About the Project
A key objective in personalized oncology is identifying the drug-sensitivity profile of a patient’s cancer to a wide spectrum of different drugs. In this project, a new method will be developed for the rapid identification of the drug-sensitivity profile of a specific type of ovarian cancer to numerous drugs. The multidisciplinary team brings together scientists from diverse fields, including nanoparticles, nanochemistry, cancer biology, pathology, and systems biology. Using smart, stimulus-responsive nanoparticles, the team will simultaneously screen the ability of multiple drugs to kill cancer cells in vivo.
Research Team
Prof. Eli Pikarsky
School of Medicine, The Hebrew University of Jerusalem (Immunology and Cancer Research and Department of Pathology)
Prof. Itamar Willner
The Hebrew University of Jerusalem (Institute of Chemistry)
Dr. Oren Parnas
The Hebrew University of Jerusalem (Immunology and Cancer Research)
Prof. Rachel Nechushtai
The Hebrew University of Jerusalem (Plant and Environmental Sciences)
Video
More Projects Funded